SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 11, 2003
The Medicines Company
(Exact Name of Registrant as Specified in Charter)
Delaware 000-31191 04-3324394
--------------------------- ------------ ------------------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
5 Sylvan Way, Suite 200
Parsippany, New Jersey 07054
--------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (973) 656-1616
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
On February 11, 2003, The Medicines Company announced its financial
results for the quarter and full year period ended December 31, 2002.
The full text of the press release issued in connection with the
announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is
incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
Exhibit No. Description
99.1 Press release dated February 11, 2003 entitled "The
Medicines Company Reports Fourth Quarter and Full Year
2002 Financial Results."
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: February 13, 2003 THE MEDICINES COMPANY
By: /s/ Steven H. Koehler
-----------------------------
Steven H. Koehler
Vice President and Chief
Financial Officer
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release dated February 11, 2003 entitled "The
Medicines Company Reports Fourth Quarter and Full Year
2002 Financial Results."